tetano
Editor, Senior Moderator
J Med Virol. 2020 Feb 19. doi: 10.1002/jmv.25711. [Epub ahead of print] [h=1]The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019.[/h]
Han W[SUP]1[/SUP], Quan B[SUP]2[/SUP], Guo Y[SUP]3[/SUP], Zhang J[SUP]4[/SUP], Lu Y[SUP]5[/SUP], Feng G[SUP]1[/SUP], Wu Q[SUP]1[/SUP], Fang F[SUP]1[/SUP], Cheng L[SUP]1[/SUP], Jiao N[SUP]6[/SUP], Li X[SUP]1[/SUP], Chen Q[SUP]7[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] A pneumonia outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first identified in Wuhan, present a major threat to public health since December 2019. There are more than 50,000 confirmed cases and 1300 dead cases worldwide for the past month or more, because of the occurrence of a highly contagious performance. Patients had clinical manifestations of fever, cough, shortness of breath, diarrhea, vomiting and so on. We herein report a case of SARS-CoV-2, describe the epidemic history, clinical diagnosis and the changes of clinical parameters during the combination therapy. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
[h=4]KEYWORDS:[/h] COVID-19; SARS-CoV-2; lopinavir and ritonavir tablets; severe respiratory syndrome
PMID: 32073161 DOI: 10.1002/jmv.25711
Han W[SUP]1[/SUP], Quan B[SUP]2[/SUP], Guo Y[SUP]3[/SUP], Zhang J[SUP]4[/SUP], Lu Y[SUP]5[/SUP], Feng G[SUP]1[/SUP], Wu Q[SUP]1[/SUP], Fang F[SUP]1[/SUP], Cheng L[SUP]1[/SUP], Jiao N[SUP]6[/SUP], Li X[SUP]1[/SUP], Chen Q[SUP]7[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] A pneumonia outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first identified in Wuhan, present a major threat to public health since December 2019. There are more than 50,000 confirmed cases and 1300 dead cases worldwide for the past month or more, because of the occurrence of a highly contagious performance. Patients had clinical manifestations of fever, cough, shortness of breath, diarrhea, vomiting and so on. We herein report a case of SARS-CoV-2, describe the epidemic history, clinical diagnosis and the changes of clinical parameters during the combination therapy. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
[h=4]KEYWORDS:[/h] COVID-19; SARS-CoV-2; lopinavir and ritonavir tablets; severe respiratory syndrome
PMID: 32073161 DOI: 10.1002/jmv.25711